| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2478292 | Annales Pharmaceutiques Françaises | 2007 | 5 Pages |
Abstract
Such information is integrated into a risk management strategy, defined together by the French drug agency (Afssaps) and the marketing authorization holder. This strategy includes a pharmacovigilance plan and, if possible, a risk minimisation plan.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
J.-L. Imbs, M. Welsch,